Treating osteoporosis in post-menopausal women: A case approach
Michael I. Keller, MD
San Diego Arthritis and Osteoporosis Research, San Diego, CA
Address: Michael I. Keller, MD, 5555 Reservoir Drive, Suite 202, San Diego, CA 92120; e-mail Mkellermd@aol.com
The author has indicated that he has received grant or research support from the Wyeth, Pfizer, Proctor and Gamble, Sanofi, NPS, and Alexis corporations and is on the speakers’ bureaus of the Abbott, Merck, and Proctor and Gamble corporations.
This paper discusses treatments that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.
ABSTRACTWe now have several agents of different classes for treating postmenopausal osteoporosis. In this paper, a case report serves as the focus for a discussion of the risk factors for postmenopausal osteoporosis and of the available therapies.